Trevi Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TRVI Nasdaq 2834 www.trevitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trevi Therapeutics, Inc.

Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - Jun 5th, 2025 2:30 pm
Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock - Jun 3rd, 2025 8:15 pm
Trevi Therapeutics Announces Proposed Public Offering of Common Stock - Jun 2nd, 2025 2:01 pm
Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough - Jun 2nd, 2025 5:00 am
Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough - Jun 1st, 2025 2:00 pm
H.C. Wainwright Initiates Coverage of Trevi Therapeutics (TRVI) With Buy Rating - May 29th, 2025 12:52 pm
Trevi Therapeutics to Participate in Upcoming June Conferences - May 29th, 2025 5:30 am
Trevi Therapeutics Announces Additional Analyses from Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough - May 20th, 2025 5:00 am
Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High? - May 14th, 2025 7:55 am
Trevi Therapeutics Inc (TRVI) Q1 2025 Earnings Call Highlights: Promising Trial Results and ... - May 9th, 2025 1:43 am
Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - May 8th, 2025 2:05 pm
Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025 - May 1st, 2025 2:05 pm
Trevi Therapeutics to Participate in Upcoming April Investor Conferences - Apr 3rd, 2025 5:30 am
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Mar 26th, 2025 5:00 am
Trevi Therapeutics Inc (TRVI) Q4 2024 Earnings Call Highlights: Navigating Losses and Advancing ... - Mar 19th, 2025 1:02 am
Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates - Mar 18th, 2025 2:05 pm
Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) large institutional owners must be happy as stock continues to impress, up 57% over the past week - Mar 16th, 2025 8:04 am
Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025 - Mar 11th, 2025 2:05 pm
TRVI Stock Soars on Meeting Primary Goal in Chronic Cough Study - Mar 11th, 2025 7:56 am
Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps - Mar 10th, 2025 9:30 am